Hyderabad: Nearly a year and a half after its subsidiary, Auro Vaccines Pvt Ltd, inked a licensing pact with Hilleman ...
Aurobindo Pharma has terminated a license agreement through its subsidiary Auro Vaccines with Hilleman Laboratories for ...
The company isn't content with just one area of focus; it's actively expanding into new verticals like injectables, peptides, ...
Aurobindo Pharma on Wednesday said its subsidiary has terminated a license agreement with Singapore-based Hilleman ...
Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent ...
Aurobindo Pharma's subsidiary Auro Vaccines has terminated a license agreement with Singapore-based Hilleman Laboratories for ...
Hyderabad: Aurobindo Pharma has announced that Auro Vaccines Private Limited, a wholly owned step-down subsidiary of the ...
1d
ET Now on MSNAurobindo's CuraTeq Biologics Aims Doubling Down on Biosimilar Launches - 2031 Plans REVEALED | ET NOW On The Go Hyderabad EditionAurobindo, that last year signed a deal with U.S. drugmaker MSD to manufacture one of their biologics products at its ...
10don MSN
Brokerages issued updated recommendations on Balkrishna Industries, Varun Beverages, and Aurobindo Pharma. Balkrishna sees ...
Aurobindo Pharma will begin supplying drugs to Europe from its new China facility starting in April. The company expects significant revenue growth from the plant over the next few years. New Delhi, ...
Aurobindo Pharma's subsidiary terminates pentavalent vaccine agreement with Hilleman Laboratories Singapore, no significant impact expected on company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results